AKT1 and non-small cell lung carcinoma: The PIK3R2 protein serves as a regulatory component of PI3K, and targeting PIK3R2 could inhibit the proliferation, migration, and invasion of NSCLC A549 cells by modulating the PTEN/PI3K/AKT pathway [35].